Prognostic factors and long‐term follow‐up of basiliximab for steroid‐refractory acute graft‐versus‐host disease : Updated experience from a large‐scale study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic factors and long‐term follow‐up of basiliximab for steroid‐refractory acute
graft‐versus‐host disease
: Updated experience from a large‐scale study
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-21
DOI
10.1002/ajh.25839
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
- (2020) Olaf Penack et al. Lancet Haematology
- The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide
- (2019) Jacopo Mariotti et al. BONE MARROW TRANSPLANTATION
- Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation
- (2019) Sameem Abedin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients
- (2019) Yu Wang et al. Journal of Hematology & Oncology
- Basiliximab as Treatment for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients after Haploidentical Hematopoietic Stem Cell Transplantation
- (2019) Fei-Fei Tang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease
- (2019) Donna Przepiorka et al. ONCOLOGIST
- EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
- (2018) Helene M. Schoemans et al. BONE MARROW TRANSPLANTATION
- The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology
- (2018) Lanping Xu et al. Journal of Hematology & Oncology
- The role of collateral related donors in haploidentical hematopoietic stem cell transplantation
- (2018) Xiao-Dong Mo et al. Science Bulletin
- Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant
- (2017) Lan-Ping Xu et al. Journal of Hematology & Oncology
- Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy
- (2017) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD
- (2016) Gérard Socié et al. BLOOD
- Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease
- (2016) I García-Cadenas et al. BONE MARROW TRANSPLANTATION
- A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality
- (2015) Margaret L. MacMillan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
- (2015) Madan H. Jagasia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
- (2015) Yu Wang et al. BLOOD
- The use of basiliximab–infliximab combination for the treatment of severe gastrointestinal acute GvHD
- (2015) M Nadeau et al. BONE MARROW TRANSPLANTATION
- Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody
- (2015) Geothy Chakupurakal et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients
- (2015) T Tao et al. Blood Cancer Journal
- Who is the best donor for a related HLA haplotype-mismatched transplant?
- (2014) Y. Wang et al. BLOOD
- Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
- (2013) Joanne Kurtzberg et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Long-term follow-up of corticosteroid refractory acute GVHD treated with an Inolimomab-based algorithm: a single center experience
- (2013) S Girerd et al. BONE MARROW TRANSPLANTATION
- First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
- (2012) Paul J. Martin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Diagnosis and management of acute graft-versus-host disease
- (2012) Fiona L. Dignan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Basiliximab for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease After Unmanipulated HLA-Mismatched/Haploidentical Hematopoietic Stem Cell Transplantation
- (2011) J.Z. Wang et al. TRANSPLANTATION PROCEEDINGS
- Therapy with mycophenolate mofetil for refractory acute and chronic GVHD
- (2009) T Furlong et al. BONE MARROW TRANSPLANTATION
- Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation
- (2009) P J Shaughnessy et al. BONE MARROW TRANSPLANTATION
- Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease
- (2009) J Pidala et al. BONE MARROW TRANSPLANTATION
- Improved Survival and Preserved Antiviral Responses After Combination Therapy With Daclizumab and Infliximab in Steroid-refractory Graft-Versus-Host Disease
- (2009) Kanchan Rao et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes
- (2008) M. Mielcarek et al. BLOOD
- Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience
- (2008) M Miano et al. BONE MARROW TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started